US › Healthcare

Delcath Systems Inc (DCTH)

US · Healthcare · Medical Devices

$13.14+0.77%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$25.0M
Revenue YoY
+26.3%
Net profit
$-1.1M
Profit YoY
-200.1%
EPS
$-0.03
EPS estimate
$-0.09
Net margin
-4.3%

EPS came in at -0.03 against a street estimate of -0.09 — a beat of 66.7%.

Key statistics

Market cap
$450.2M
P/E
1,304.0
Forward P/E
25.8
P/B
3.74
Book value
$3.27
EPS (TTM)
$0.01
52-week high
$13.74
52-week low
$8.12
50-day MA
$12.01
200-day MA
$10.47
Beta
0.52

Analyst view

Analysts rate Delcath Systems Inc a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $21.55.

Shareholding

Insiders
8.13%
Institutions
49.13%

Largest institutional holders

FundStake
Rosalind Advisors, Inc.9.56%
BlackRock Inc5.17%
Vanguard Group Inc4.84%
Vanguard Capital Management, LLC3.85%
Propel Bio Management LLC2.84%
Geode Capital Management, LLC2.00%
State Street Corp1.92%
Private Wealth Advisors, LLC1.71%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Delcath Systems Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.